BNGO
Bionano Genomics Inc
NASDAQ: BNGO · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$1.16
-2.52% today
Updated 2026-04-29
Market cap
$13.42M
P/E ratio
—
P/S ratio
0.47x
EPS (TTM)
$-4.85
Dividend yield
—
52W range
$1 – $6
Volume
0.3M
WallStSmart proprietary scores
31
out of 100
Grade: F
Strong Sell
Investment rating
3.3
Growth
D6.5
Quality
B2.0
Profitability
F6.7
Valuation
B4/9
Piotroski F-Score
Moderate
-13.2
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →206 stocks currently score above 75
Price targets
Analyst target
$5.00
+331.03%
12-Month target
—
—
Intrinsic (DCF)
$11.03
Margin of safety
+89.66%
1 Strong Buy1 Buy0 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
+ 89.66% below intrinsic value
+ Debt/equity 0.15x — low leverage
Risks
- Altman Z -13.17 — distress zone
- Thin margins at -92.60%
- Negative free cash flow $-4.17M
- Revenue declining -2.60% QoQ
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $27.80M | $36.12M | $30.78M | $28.51M | $28.51M |
| Net income | $-132.60M | $-232.49M | $-112.02M | $-26.39M | $-7.93M |
| EPS | — | — | — | — | $-4.85 |
| Free cash flow | $-128.12M | $-126.87M | $-69.03M | $-16.34M | $-4.17M |
| Profit margin | -476.93% | -643.74% | -363.98% | -92.59% | -92.60% |
Peer comparison
Smart narrative
Bionano Genomics Inc trades at $1.16. Our Smart Value Score of 31/100 indicates the stock is weak. The company scores 4/9 on the Piotroski F-Score. With an Altman Z-Score of -13.17, it sits in the distress. TTM revenue stands at $28.51M. with profit margins at -92.60%. Our DCF model estimates intrinsic value at $11.03.
Frequently asked questions
What is Bionano Genomics Inc's stock price?
Bionano Genomics Inc (BNGO) trades at $1.16.
Is Bionano Genomics Inc overvalued?
Smart Value Score 31/100 (Grade F, Strong Sell). DCF value $11.03.
What is the price target of Bionano Genomics Inc (BNGO)?
The analyst target price is $5.00, representing +331.0% upside from the current price of $1.16.
What is the intrinsic value of Bionano Genomics Inc (BNGO)?
Based on our DCF model, intrinsic value is $11.03, a +89.7% margin of safety versus $1.16.
What is Bionano Genomics Inc's revenue?
TTM revenue is $28.51M.
Piotroski F-Score?
4/9 — moderate financial health.
Altman Z-Score?
-13.17 — distress.
Company info
SectorHEALTHCARE
IndustryMEDICAL INSTRUMENTS & SUPPLIES
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio0.47x
ROE-66.10%
Beta1.60
50D MA$1.17
200D MA$1.97
Shares out0.01B
Float0.01B
Short ratio—
Avg volume0.3M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—